Sector: Pharmaceuticals

Latest content

Pfizer’s opposition against registration of RUXXIMLA partially successful

The case confirms that the high degree of attention of the relevant public in respect of goods/services related to the medical field does not automatically rule out the existence of a likelihood of confusion.

26 November 2021

Johnson & Johnson decides bigger is not better

The corporate schism will enable the company to spend more time nurturing and promoting its household brands.

19 November 2021

Inside the battle against illegal online pharmacies: interview with ASOP Global

WTR sits down with Libby Baney from the Alliance for Safe Online Pharmacies to get the inside track on their efforts to combat illegal online drug sales.

28 October 2021

A danger to millions: why counterfeiting should be included among crimes against humanity

With a petition set for the International Criminal Court, it is about time the dangers of counterfeit goods are considered among the list of crimes against humanity, argues our Saturday opinion.

23 October 2021

Covid and counterfeits: how brand owners are fighting back against pandemic opportunists

In an exclusive guest post, experts at Gowling look at how brand owners have tackled a significant rise in counterfeit goods during the covid-19 pandemic.

21 October 2021

HELIOS v HEALIOS: General Court considers likelihood of confusion in the medical field

This decision of the General Court highlights that, when it comes to goods and services with a medical purpose, it might not be sufficient to argue that their ultimate purpose can overlap with their medical application in order to establish similarity.

20 October 2021

Nigeria’s counterfeiting epidemic: expert outlines what brands can do to fight back

The co-author of a new study into Nigerian counterfeits reveals what international brand owners and IP associations can do to improve the situation.

07 October 2021

A different finding by the Full Court: PROTOX found to infringe BOTOX mark

The Full Court of the Federal Court of Australia has overturned the first-instance decision in this dispute between Allergan - the owner of the BOTOX mark - and Self Care over the latter’s use of the mark PROTOX.

24 September 2021

Inconsistency, fraud, laundering – research decries challenges for cannabis companies at the USPTO

A new study has investigated the so-called ‘trademark laundering trap’ that cannabis companies face if they seek brand protection at the USPTO.

15 September 2021

As evidence of plain packaging ineffectiveness grows, a less brand-restrictive alternative must be considered

In an exclusive opinion column, Axess Technologies chair Richard Jotcham gives an alternative perspective on plain packaging since it was first introduced for tobacco products nearly a decade ago.

21 August 2021

Get unlimited access to all WTR content